ORITAVANCIN vs ORITAVANCIN DIPHOSPHATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ORITAVANCIN vs ORITAVANCIN DIPHOSPHATE: Safety Overview
| Metric | ORITAVANCIN | ORITAVANCIN DIPHOSPHATE |
|---|---|---|
| Total FAERS Reports | 884 | 276 |
| Deaths Reported | 29 | 4 |
| Death Rate | 3.3% | 1.4% |
| Hospitalizations | 157 | 27 |
| Average Patient Age | 55.9 yrs | 58.5 yrs |
| % Female Patients | 52.2% | 39.2% |
| FDA Approval Date | N/A | Aug 6, 2014 |
| Manufacturer | Melinta Therapeutics, LLC | Melinta Therapeutics, LLC |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | N/A | Prescription |